SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-003668
Filing Date
2022-03-15
Accepted
2022-03-15 08:32:54
Documents
69
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ovid-20211231.htm   iXBRL 10-K 2805426
2 EX-23.1 ovid-ex23_1.htm EX-23.1 3156
3 EX-31.1 ovid-ex31_1.htm EX-31.1 11741
4 EX-31.2 ovid-ex31_2.htm EX-31.2 12013
5 EX-32.1 ovid-ex32_1.htm EX-32.1 12937
6 GRAPHIC img41469671_0.jpg GRAPHIC 74672
7 GRAPHIC img41469671_1.jpg GRAPHIC 552588
  Complete submission text file 0000950170-22-003668.txt   10574352

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ovid-20211231.xsd EX-101.SCH 50626
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ovid-20211231_def.xml EX-101.DEF 229597
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ovid-20211231_cal.xml EX-101.CAL 48772
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ovid-20211231_pre.xml EX-101.PRE 356722
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ovid-20211231_lab.xml EX-101.LAB 477922
63 EXTRACTED XBRL INSTANCE DOCUMENT ovid-20211231_htm.xml XML 1512637
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38085 | Film No.: 22739232
SIC: 2834 Pharmaceutical Preparations